Latest filing published 06 Jan 2020 for MEDICINES CO /DE.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -13.3%Entry US$210.00 · Close at T+365 US$182.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Paris Panayiotopoulos: trading record in brief
This profile gathers the share dealings of Paris Panayiotopoulos across 3 companies, led by Ariad Pharmaceuticals Inc, Medicines Co /DE and Corbus Pharmaceuticals Holdings, Inc. In total, 13 filings cover trades dated from 1 February 2016 to 6 January 2020.
No open-market sale appears; the market trades are 4 purchases worth €622k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 5 share grants and 2 option exercises.
A typical purchase (the median) is worth €130k. Of 4 purchases, 2 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 6 January 2020, the filings show a transaction in Medicines Co /DE. The last purchase on record was published on 1 December 2017, which is 3,264 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paris Panayiotopoulos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,881 sharesCommon StockSEC:0000950142-20-000046:0
- 3,663 shares0Common StockSEC:0001179110-19-007028:0
- 3,766 shares0Common StockSEC:0001179110-18-007956:0
- 3,215 shares@ US$30.97100.0% of flowCommon StockSEC:0001179110-17-014789:0Canonical exit: 28 Feb 2018 (T+90)
- 14,285 shares@ US$7.03100.0% of flowCommon StockSEC:0001209191-17-061358:0Canonical exit: 14 Feb 2018 (T+90)
- 3,237 shares0Common StockSEC:0001179110-17-008215:0
- 159,378 sharesCommon StockSEC:0000884731-17-000051:0
- 66,600 shares0Common StockSEC:0000884731-17-000004:0
- 33,300 shares@ US$23.6953.9% of flowCommon StockSEC:0000884731-17-000004:1
- 66,600 shares0Common StockSEC:0000884731-16-000085:0
- 28,611 shares@ US$7.1413.3% of flowCommon StockSEC:0000884731-16-000085:1
- 26,990 shares@ US$7.4112.7% of flowCommon StockSEC:0000884731-16-000057:0Canonical exit: 10 Aug 2016 (T+90)
- 61,099 shares@ US$4.91100.0% of flowCommon StockSEC:0001127602-16-039363:0Canonical exit: 1 May 2016 (T+90)
13 of 13 declarations
